StockData
ADC Therapeutics SA logo

ADC Therapeutics SA (ADCT) stock

ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.35+0.10 (+8.00%)

Close on Nov 17, 2026Market cap $172.35MP/E –Yield –

ADC Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for ADC Therapeutics

ADC Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More ADC Therapeutics figures

See a number that looks wrong?